Discussion
We consider the first 12 months of this new MDT service a success. We received a large number of referrals and were able to see many patients at high risk of negative diabetes related outcomes in the peri-operative period. Anecdotally we feel the interventions achieved significant risk reduction for many patients although analysis of these interventions continues.
Factors that contributed to success
- A high demand for this service as evidenced by large number of patients with diabetes having elective surgery at the Princess Alexandra Hospital and increasing complexity of diabetes management including use of diabetes technology and medications that are associated with perioperative risks including GLP-1RA and SGLT2i.
- Consultation with and buy in from the perioperative anaesthetic, pharmacy and nursing services who recognise the importance and impact of improving peri-operative diabetes management.
- A multi-disciplinary expert clinical team to provide evidence-based interventions supported by diabetes technology use as resources allowed.
Strengths
- High attendance rates for new referrals as patients with diabetes are motivated to reduce the risk of surgery being delayed or peri-operative complications.
- Being situated within the pre-admission clinic allowed clear communication pathways for perioperative anaesthetic service and nursing staff to facilitate opportunistic reviews and coordinate simultaneous reviews to minimise appointment burden on patients.
- We were able to identify many patients who needed but have no dedicated diabetes speciality oversight and ensure appropriate follow up post operatively to reduce future risk.
- We were able to proactively link our inpatient diabetes service to ensure timely diabetes speciality reviews post-operatively to optimise diabetes-related outcomes in hospital.
Limitations
The limitations of the service centres around the referral process.
Receiving referrals only a short time before (<2 weeks) prior to surgical booking date gives limited opportunity to assess, intervene and provide final recommendations. We were unable to see a number of patients that would have benefited from our service due to restricted time to surgery.
We continue to look for ways in which we can effective proactively identified high risk patients and coordinate review once waitlisted, rather than waiting until surgical date provided.
We liaised with the PAH casemix team to create a weekly report of patients with history of diabetes who are on the surgical waitlist.
We have requested upgrade of the Glucose Assessment for Inpatient (GAIN) dashboard through the QLD Diabetes Network and OCCIO to facilitate more effective use of the Pre-admitted patient view which may be useful in proactively identifying patients at high risk.
We continue to liaise with our surgical colleagues to promote early referral at the time of surgical bookings.
We feel that this model of care is highly valuable and beneficial for people living with diabetes who are undergoing elective surgery, the clinical staff caring for these patients during inpatient admission and for health services where in hospital diabetes complications are financially burdensome.
This diabetes-specialty lead model of care is simple and could be utilised across metro south sites. The improved use of clinical data to proactively identify the highest risk patients would improve patient identification and clinic efficiency.
References
1.Yu A, Truong Q, Whitfield K, Hale A, Taing MW, Barker N, et al. Impact of preoperative haemoglobin A(1c) levels on postoperative outcomes in adults undergoing major noncardiac surgery: A systematic review. Diabet Med. 2024:e15380.
2.Anaesthetists ADSaANZCo. ADS-ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (Adults). 2022.